Beranda › Judul Pekerjaan › Senior Biostatistician
Gaji H-1B untuk Senior Biostatistician
110 aplikasi kondisi tenaga kerja menggunakan jabatan Senior Biostatistician. Gaji pokok median yang ditawarkan $123.674; setengah tengah $93.870–$138.474.
Lamaran (LCA)110
Median gaji yang ditawarkan$123.674
Setengah bagian tengah gaji$93.870–$138.474
Persentil ke-10 hingga ke-90$81.950–$148.103
Pengacara imigrasi, perekrut, atau pemberi kerja? Tampilkan layanan Anda di bagian atas halaman ini — $99 selama 30 hari →
Pemberi Kerja
| Pemberi Kerja | LCA | Median Gaji |
|---|
| IQVIA RDS Inc. | 9 | $139.322 |
| Vanderbilt University Medical Center | 7 | $93.000 |
| Cytel Inc. | 6 | $135.000 |
| Daiichi Sankyo, Inc. | 6 | $141.386 |
| Baylor College of Medicine | 6 | $90.000 |
| Natera, Inc. | 6 | $128.361 |
| Cleveland Clinic Foundation | 5 | $72.301 |
| Syneos Health, LLC | 5 | $110.000 |
| Parexel International LLC | 4 | $133.606 |
| TechData Service Company LLC | 4 | $145.000 |
| St. Jude Children's Research Hospital | 3 | $93.870 |
| Foundation Medicine, Inc. | 3 | $137.966 |
| Fortrea Inc. | 3 | $99.861 |
| Redbock LLC | 3 | $137.280 |
| Health Research Inc. - Roswell Park Division | 2 | $96.559 |
| CareDx, Inc | 2 | $144.821 |
| Ionis Pharmaceuticals, Inc. | 2 | $100.222 |
| Axio Research, LLC | 2 | $108.962 |
| ClinChoice Inc. | 2 | $122.282 |
| Mount Sinai Hospital | 2 | $102.182 |
| PreciseDx, Inc. | 2 | $180.000 |
| Alexion Pharmaceuticals, Inc. | 2 | $141.400 |
| Fulcrum Therapeutics, Inc. | 1 | $115.000 |
| Tempus Labs, Inc. | 1 | $135.000 |
| WCG Clinical, Inc. | 1 | $59.155 |
| Adventist Health System/Sunbelt, Inc. | 1 | $83.241 |
| Abbott Molecular Inc. | 1 | $86.000 |
| NJS Associates Company | 1 | $165.000 |
| NYU Grossman School of Medicine | 1 | $137.800 |
| Pharmaron US Clinical Services, Inc. | 1 | $75.000 |
| Safety & Efficacy IT Solutions Inc. | 1 | $103.000 |
| BeiGene USA, Inc. | 1 | $135.000 |
| Thomas Jefferson University | 1 | $90.000 |
| Roche Molecular Systems, Inc. | 1 | $124.238 |
| General Hospital Corporation | 1 | $87.246 |
| Karyopharm Therapeutics Inc. | 1 | $187.044 |
| Sanofi Pasteur Inc. | 1 | $100.500 |
| Cerus Corporation | 1 | $150.000 |
| Beckman Coulter, Inc. | 1 | $111.375 |
| Biosense Webster, Inc. | 1 | $145.000 |
| Zimmer, Inc. | 1 | $127.810 |
| Abbott Diabetes Care Inc. | 1 | $123.000 |
| Everest Clinical Research Corporation | 1 | $130.000 |
| Cardiovascular Research Foundation | 1 | $119.000 |
| BeOne Medicines US Manufacturing Co., Inc. | 1 | $144.200 |
| Medical Device Business Services, Inc. | 1 | $130.000 |
Berdasarkan Tingkat Upah
| Level Upah | Median Gaji |
|---|
| Level I (pemula) | $92.500 |
| Level II (berkualifikasi) | $123.000 |
| Level III (berpengalaman) | $135.352 |
| Level IV (kompeten penuh) | $159.000 |
Departemen Tenaga Kerja menetapkan empat level upah yang berlaku untuk setiap pekerjaan dan area, dari Level I (pemula) hingga Level IV (kompeten penuh). Pemberi kerja memilih level yang sesuai dengan persyaratan pekerjaan.
Berdasarkan Tahun Fiskal
| Tahun Fiskal | LCA | Median Gaji |
|---|
| FY2023 | 30 | $114.462 |
| FY2024 | 27 | $112.258 |
| FY2025 | 33 | $127.810 |
| FY2026 | 18 | $127.500 |
Kota
- Houston, TX7
- Nashville, TN6
- Basking Ridge, NJ6
- Cleveland, OH5
- New York, NY4
- Memphis, TN3
- Medford, MA3
- Bellevue, WA3
- Durham, NC3
- Jersey City, NJ3
- Buffalo, NY2
- Billerica, MA2
- Cambridge, MA2
- Carlsbad, CA2
- Fort Washington, PA2
- Seattle, WA2
- San Jose, CA2
- New Haven, CT2
- San Carlos, CA2
- King of Prussia, PA2
- Irvine, CA2
- West Lafayette, IN1
- Raritan, NJ1
- Los Angeles, CA1
- Seabrook, TX1
- Orlando, FL1
- Foster City, CA1
- North Billerica, MA1
- Rockville, MD1
- Des Plaines, IL1
Gaji adalah batas bawah dari upah yang ditawarkan pada setiap aplikasi, dikonversi menjadi jumlah tahunan; statistik hanya menggunakan aplikasi penuh waktu yang tersertifikasi. LCA bukan persetujuan visa dan satu LCA dapat mencakup beberapa posisi. Sumber: Data Pengungkapan LCA OFLC, Departemen Tenaga Kerja AS, tahun fiskal 2023–2026 (keputusan terbaru 30 Jun 2026).